Ainos, Inc.
Ainos, Inc.
- Market cap
- $3.64M
Your view on AIMDW
Overview
What the company does, where it operates, and who runs it.
About Ainos, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chun-Hsien Tsai
- Headquarters
- 3050 Post Oak Boulevard, Houston, TX, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chun-Hsien Tsai
- Headquarters
- 3050 Post Oak Boulevard, Houston, TX, US
Ainos, Inc. operates as a healthcare enterprise dedicated to advancing medical technologies. Its core focus involves developing both point-of-care diagnostic solutions and innovative, safe therapeutic options for various health conditions. The company's offerings include a COVID-19 antigen rapid test kit.
This is complemented by the Ainos' cloud-based test management App, a holistic platform comprising the rapid test kit, a personal mobile application, and an enterprise-level app. Ainos also provides a COVID-19 nucleic acid test.
Further technologies under development or offered include point-of-care testing for volatile organic compounds and Very Low-Dose Oral Interferon Alpha, an oral formulation of IFN-a with broad therapeutic potential. The firm is additionally developing a Synthetic RNA (SRNA) technology platform, with specific work being conducted in Taiwan.
Beyond these, Ainos' product line extends to women's health, pneumonia, the Ainos Pen, AI Nose, and a variety of other products. Originally incorporated in 1984, the company was formerly known as Amarillo Biosciences, Inc. and rebranded to Ainos, Inc. in May 2021. Its main operations are based in San Diego, California.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Ainos, Inc.. Starting points for Ainos, Inc.: EPS -$1.81, beta 2.17 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Ainos, Inc.. Trailing twelve-month EPS for Ainos, Inc. stands at -$1.81. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Ainos, Inc.. Ainos, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| APLIFAppili Therapeutics Inc. | Healthcare | Biotechnology | $1.7M | ||
| AZTRAzitra, Inc. | Healthcare | Biotechnology | $3.5M | ||
| BCTXZBriaCell Therapeutics Corp. Warrant | Healthcare | Biotechnology | $239,235 | ||
| CDTCDT Equity Inc. | Healthcare | Biotechnology | $159,886 | ||
| CLABFCore One Labs Inc. | Healthcare | Medical - Pharmaceuticals | $500 | ||
| REVBRevelation Biosciences, Inc. | Healthcare | Biotechnology | $2.2M | ||
| VAXXVaxxinity, Inc. | Healthcare | Biotechnology | $25,357 | ||
| VRAXVirax Biolabs Group Limited | Healthcare | Biotechnology | $578,345 | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BCHMFBachem Holding AG | Healthcare | OTC | $4.5B | ||
| BCLIBrainstorm Cell Therapeutics Inc. | Healthcare | OTC | $6.8M | ||
| BCRXBioCryst Pharmaceuticals, Inc. | Healthcare | NASDAQ | $1.9B | ||
| BCT.TOBriaCell Therapeutics Corp. | Healthcare | TSX | $40.6M | ||
| BCTXBriaCell Therapeutics Corp. | Healthcare | NASDAQ | $28.6M | ||
| BCYCBicycle Therapeutics plc | Healthcare | NASDAQ | $218.0M | ||
| BDRXBiodexa Pharmaceuticals Plc | Healthcare | NASDAQ | $189,830 | ||
| BDTXBlack Diamond Therapeutics, Inc. | Healthcare | NASDAQ | $82.2M | ||
| BEAMBeam Therapeutics Inc. | Healthcare | NASDAQ | $2.2B | ||
| BETR.CNBetterLife Pharma Inc. | Healthcare | CNQ | — | ||
| BETRFBetterLife Pharma Inc. | Healthcare | OTC | $6.4M | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Ainos, Inc. executives and directors. Shares of Ainos, Inc. have traded between $0.10 and $0.17 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Ainos, Inc.. Coverage tracks Ainos, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Ainos, Inc.